Win Advisors’s Thermo Fisher Scientific TMO Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
Sell
-1,521
Closed -$881K 119
2025
Q4
$881K Buy
1,521
+577
+61% +$326K 0.37% 53
2025
Q3
$458K Buy
+944
New +$439K 0.22% 52
2023
Q1
Sell
-56
Closed -$30.8K 138
2022
Q4
$30.8K Buy
+56
New +$29.7K 0.01% 63

Other funds holding TMO

Win Advisors's TMO Position: Q1 2026 in Review

Win Advisors sold out of Thermo Fisher Scientific (TMO) in Q1 2026, closing a stake of 1,521 shares — an estimated $881K sold.

Win Advisors first reported a position in TMO in Q4 2022 and held it in 3 quarters. The position peaked at $881K in Q4 2025. 2,590 funds tracked by Wall St. Rank hold TMO as of Q1 2026.

  • Win Advisors reported no remaining Thermo Fisher Scientific position as of Q1 2026 after selling out during the quarter.
  • Win Advisors sold 1,521 Thermo Fisher Scientific shares in Q1 2026, an estimated $881K.
  • Win Advisors first reported a position in Thermo Fisher Scientific in Q4 2022 and held it in 3 quarters.
  • Win Advisors's Thermo Fisher Scientific position peaked at $881K in Q4 2025.
  • 2,590 funds tracked by Wall St. Rank held Thermo Fisher Scientific as of Q1 2026.

Based on Win Advisors's 13F filing for Q1 2026, filed 1 May 2026.